rabeprazole and Gastric Diseases
rabeprazole has been researched along with Gastric Diseases in 6 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Research
Studies (6)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors
Authors | Studies |
---|---|
Jung, YS | 2 |
Kim, S | 2 |
Kim, HY | 2 |
Noh, SJ | 2 |
Park, JH | 2 |
Sohn, CI | 2 |
Park, CH | 2 |
Kawasaki, K | 1 |
Kurahara, K | 1 |
Oshiro, Y | 1 |
Ohtsu, K | 1 |
Nakamura, S | 1 |
Fuchigami, T | 1 |
Matsumoto, T | 1 |
Hwang, JJ | 1 |
Lee, DH | 1 |
Lee, AR | 1 |
Yoon, H | 1 |
Shin, CM | 1 |
Park, YS | 1 |
Kim, N | 1 |
Wu, DC | 1 |
Kuo, CH | 1 |
Tsay, FW | 1 |
Hsu, WH | 1 |
Chen, A | 1 |
Hsu, PI | 1 |
Osipenko, MF | 1 |
Konstantinov, VI | 1 |
Moiseenko, EE | 1 |
Bikbulatova, EA | 1 |
Kawai, T | 1 |
Kawakami, K | 1 |
Mikinori, K | 1 |
Takei, K | 1 |
Itoi, T | 1 |
Moriyasu, F | 1 |
Takagi, Y | 1 |
Aoki, T | 1 |
Watanebe, K | 1 |
Matsumoto, Y | 1 |
Rimbara, E | 1 |
Noguchi, N | 1 |
Sasatsu, M | 1 |
Trials
3 trials available for rabeprazole and Gastric Diseases
Article | Year |
---|---|
Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
Topics: Aged; Anti-Bacterial Agents; Biopsy; Breath Tests; Clarithromycin; Drug Administration Schedule; Dru | 2015 |
A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Dexlansoprazole; Drug Resistance, Bacterial; Dru | 2016 |
Efficacy of low-dose proton pump inhibitor (PPI) in the eradication of Helicobacter pylori following combination PPI/AC therapy in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarb | 2007 |
Other Studies
3 other studies available for rabeprazole and Gastric Diseases
Article | Year |
---|---|
Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infectio | 2023 |
Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infectio | 2023 |
Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infectio | 2023 |
Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infectio | 2023 |
Gastrointestinal: Idiopathic granulomatous gastritis observed by magnifying narrow-band imaging endoscopy.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combinati | 2017 |
[The first results of the program Effective Eradication in Novosibirsk].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Cities; Helicobacter Infections; Helicob | 2008 |